Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 61

Sort by

Sort Order Select

Journal Articles

The Effect of Patient Navigators on Health-Related Quality of Life in Sickle Cell Anemia: The SHIP-HU Study

Wally R Smith, MD, Donna k McClish, PhD, Shirley Johnson, BA, LSW, Richard Lottenberg, MD, India Sisler, MD, Daniel Sop, BS,MS, Anthony Villella, MD, Darla K Liles, MD, Elizabeth Yang, MD PhD, Ian Chen, MD

Blood (2019) 134 (Supplement_1): 2168.

https://doi.org/10.1182/blood-2019-131266

Published: 2019

Journal Articles

The Effect of Patient Navigators on Laboratory Parameters of Hydroxyurea Adherence in Sickle Cell Anemia: The SHIP-HU Study

Wally R Smith, MD, Donna k McClish, PhD, Richard Lottenberg, MD, India Sisler, MD, Daniel Sop, BS,MS, Shirley Johnson, BA, LSW, Anthony Villella, MD, Darla K Liles, MD, Elizabeth Yang, MD PhD, Ian Chen, MD

Blood (2019) 134 (Supplement_1): 2309.

https://doi.org/10.1182/blood-2019-131201

Published: 2019

Journal Articles

The Association of Painful Crises with Patient Reported Outcomes in Sickle Cell Disease: The SHIP-HU Study

Donna k McClish, PhD, Wally R. Smith, MD, Victoria Okhomiuna, MS, PhD, Daniel Sop Mouaffo, BS, MS, Richard Lottenberg, MD, Ian Chen, MD, India Sisler, MD, Shirley Johnson, BA, LSW, Darla K Liles, MD, Elizabeth Yang, MD PhD, Thokozeni Lipato, MD

Blood (2018) 132 (Supplement 1): 3509.

https://doi.org/10.1182/blood-2018-99-114869

Published: 2018

Journal Articles

Development of a Framework to Describe Roles and Responsibilities for Sickle Cell Community Health Workers

Joan Corder-Mabe, RN, MS, Shirley Johnson, BA, LSW, Wally R. Smith, MD, Daniel Sop Mouaffo, BS, MS, Thokozeni Lipato, MD

Blood (2018) 132 (Supplement 1): 5831.

https://doi.org/10.1182/blood-2018-99-114944

Published: 2018

Journal Articles

Access to Care, and Emergency Department Utilization for Adults and Adolescents with Sickle Cell Disease: Ascq-Me and the SHIP-HU Study

Wally R. Smith, MD, Donna k McClish, PhD, Richard Lottenberg, MD, India Sisler, MD, Thokozeni Lipato, MD, Ian Chen, MD, Shirley Johnson, BA, Ding-Yu Fei, PhD, Daniel Sop Mouaffo, MS

Blood (2017) 130 (Supplement 1): 2257.

https://doi.org/10.1182/blood.V130.Suppl_1.2257.2257

Published: 2017

Journal Articles

Comparison of Adult and Adolescent Quality of Ambulatory and Emergency Care in Sickle Cell Disease: Ascq-Me and the SHIP-HU Study

Wally R. Smith, MD, Donna k McClish, PhD, Richard Lottenberg, MD, Ian Chen, MD, Marsha J. Treadwell, PhD, San Keller, PhD, India Sisler, MD, Shirley Johnson, BA, Ding-Yu Fei, PhD, Daniel Sop Mouaffo, MS

Blood (2017) 130 (Supplement 1): 2258.

https://doi.org/10.1182/blood.V130.Suppl_1.2258.2258

Published: 2017

Journal Articles

Blood 's 70th anniversary: musings of a Blood editor, 2003-2007

Sanford J. Shattil

Blood (2016) 127 (22): 2649–2651.

https://doi.org/10.1182/blood-2015-11-635755

Published: 2016

Journal Articles

Exome Sequencing of Aggressive Natural Killer Cell Leukemia and Drug Profiling Highlight Candidate Driver Pathways in Malignant Natural Killer Cells

Blood (2015) 126 (23): 700.

https://doi.org/10.1182/blood.V126.23.700.700

Published: 2015

Journal Articles

BCR Signalosome-Oriented Phosphotyrosine Profiling of CLL

Yueming Chang, MD PhD, Jeffrey S Wasser, MD, Adam Boruchov, MD, Bruce J Mayer, PhD, Kazuya Machida, MDPhD

Blood (2015) 126 (23): 4128.

https://doi.org/10.1182/blood.V126.23.4128.4128

Published: 2015

Journal Articles

A detailed proteomic analysis of rhodocytin-activated platelets reveals novel clues on the CLEC-2 signalosome: implications for CLEC-2 signaling regulation

Andrés F. Parguiña, Jana Alonso, Isaac Rosa, Paula Vélez, María J. González-López, Esteban Guitián, Johannes A. Eble, María I. Loza, Ángel García

Blood (2012) 120 (26): e117–e126.

https://doi.org/10.1182/blood-2012-09-456004

Published: 2012

Includes: Supplemental data

Journal Articles

Mouse natural killer cell development and maturation are differentially regulated by SHIP-1

Cindy Banh, S. M. Shahjahan Miah, William G. Kerr, Laurent Brossay

Blood (2012) 120 (23): 4583–4590.

https://doi.org/10.1182/blood-2012-04-425009

Published: 2012

Includes: Supplemental data

Journal Articles

KIT's ship comes in

Benjamin S. Braun

Blood (2012) 120 (13): 2541–2542.

https://doi.org/10.1182/blood-2012-08-445247

Published: 2012

Journal Articles

Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT

Roberto Negro, Stefania Gobessi, Pablo G. Longo, Yantao He, Zhong-Yin Zhang, Luca Laurenti, Dimitar G. Efremov

Blood (2012) 119 (26): 6278–6287.

https://doi.org/10.1182/blood-2012-01-403162

Published: 2012

Includes: Supplemental data

Journal Articles

Wouldn't have happened to a Limey

Neil Abramson

Blood (2012) 119 (8): 1800.

https://doi.org/10.1182/blood-2011-05-353524

Published: 2012

Journal Articles

Disaggregation Signals Initiated by Ligand Binding and Platelet Aggregation

Cunji Gao, MD, PhD, Juan Fang, MD, Huiying Zhi, PhD, David A. Wilcox, PhD, Peter J. Newman, PhD

Blood (2011) 118 (21): 2196.

https://doi.org/10.1182/blood.V118.21.2196.2196

Published: 2011

Journal Articles

The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factor

Peilin Ma, Raghuveer Singh Mali, Veerendra Munugalavadla, Subha Krishnan, Baskar Ramdas, Emily Sims, Holly Martin, Joydeep Ghosh, Shuo Li, Rebecca J. Chan, Gerald Krystal, Andrew W. Craig, Clifford Takemoto, Reuben Kapur

Blood (2011) 118 (13): 3459–3469.

https://doi.org/10.1182/blood-2011-04-351809

Published: 2011

Journal Articles

Small Molecule SHIP Agonist AQX-MN100 Inhibits Multiple Myeloma (MM) Cell Growth In NOD/SCID Mice and Reduces Immune Suppressive Myeloid Derived Suppressor Cells (MDSC) and Regulatory T Cells (Tregs) In Mouse Model

Alice Mui, PhD, Mike Kennah, Christopher Ong, PhD, Raymond Anderson, Heather Sutherland, MD, PhD, FRCPC

Blood (2010) 116 (21): 792.

https://doi.org/10.1182/blood.V116.21.792.792

Published: 2010

Journal Articles

The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis

Gurpreet K. Lakhanpal, Laura M. Vecchiarelli-Federico, You-Jun Li, Jiu-Wei Cui, Monica L. Bailey, David E. Spaner, Daniel J. Dumont, Dwayne L. Barber, Yaacov Ben-David

Blood (2010) 116 (3): 428–436.

https://doi.org/10.1182/blood-2009-10-250217

Published: 2010

Includes: Supplemental data

Journal Articles

IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production

Kenichiro Maeda, Harshini Mehta, Douglas A. Drevets, K. Mark Coggeshall

Blood (2010) 115 (23): 4699–4706.

https://doi.org/10.1182/blood-2009-07-230631

Published: 2010

Journal Articles

SHIP1 and PTEN Co-Inactivation and Akt Pathway Targeting in ALL.

Mitchell B. Diccianni, PhD, BSc, Lisa M. Barnhill, BS, Tony Lo, BS, MS, Alice L. Yu, PhD

Blood (2009) 114 (22): 2386.

https://doi.org/10.1182/blood.V114.22.2386.2386

Published: 2009

NARROW

The Effect of Patient Navigators on Health-Related Quality of Life in Sickle Cell Anemia: The SHIP-HU Study

The Effect of Patient Navigators on Laboratory Parameters of Hydroxyurea Adherence in Sickle Cell Anemia: The SHIP-HU Study

The Association of Painful Crises with Patient Reported Outcomes in Sickle Cell Disease: The SHIP-HU Study

Development of a Framework to Describe Roles and Responsibilities for Sickle Cell Community Health Workers

Access to Care, and Emergency Department Utilization for Adults and Adolescents with Sickle Cell Disease: Ascq-Me and the SHIP-HU Study

Comparison of Adult and Adolescent Quality of Ambulatory and Emergency Care in Sickle Cell Disease: Ascq-Me and the SHIP-HU Study

Blood 's 70th anniversary: musings of a Blood editor, 2003-2007

Exome Sequencing of Aggressive Natural Killer Cell Leukemia and Drug Profiling Highlight Candidate Driver Pathways in Malignant Natural Killer Cells

BCR Signalosome-Oriented Phosphotyrosine Profiling of CLL

A detailed proteomic analysis of rhodocytin-activated platelets reveals novel clues on the CLEC-2 signalosome: implications for CLEC-2 signaling regulation

Mouse natural killer cell development and maturation are differentially regulated by SHIP-1

KIT's ship comes in

Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT

Wouldn't have happened to a Limey

Disaggregation Signals Initiated by Ligand Binding and Platelet Aggregation

The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factor

Small Molecule SHIP Agonist AQX-MN100 Inhibits Multiple Myeloma (MM) Cell Growth In NOD/SCID Mice and Reduces Immune Suppressive Myeloid Derived Suppressor Cells (MDSC) and Regulatory T Cells (Tregs) In Mouse Model

The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis

IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production

SHIP1 and PTEN Co-Inactivation and Akt Pathway Targeting in ALL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only